Nitra Rakes In $187M to Simplify the Business of Running a Healthcare Practice Read More March 10, 2026
Vertex Pharma to Seek Speedy FDA Approval for Kidney Disease Drug From $4.9B Acquisition Read More March 10, 2026
In the Absence of Objective Measures for ALS, Caregivers are the Only Witnesses. We Shouldn’t Have To Be. Read More March 10, 2026
Valuing Early-Stage Life Sciences Companies: The Why, the How, and the Impact Read More March 10, 2026
Alfasigma Pays $300M for Rights to GSK Rare Liver Disease Drug On Track for FDA Decision Read More March 9, 2026